Is a 100 mg dose of digoxin safe, and how should toxicity be managed if it is administered?

A 100 mg dose of digoxin is NEVER safe and represents a massive, potentially lethal overdose requiring immediate emergency treatment with digoxin-specific antibody fragments (digoxin-Fab).

Critical Dosing Error Recognition

The question appears to contain a critical dosing error. The standard therapeutic dose of digoxin is 0.125-0.25 mg (125-250 micrograms) daily, not 100 mg 1. A 100 mg dose represents approximately 400-800 times the normal daily dose and constitutes a massive overdose that will cause life-threatening toxicity and likely death without immediate intervention.

Immediate Management of This Massive Overdose

Life-Threatening Toxicity - Requires Immediate Digoxin-Fab

Administer digoxin-specific antibody fragments (digoxin-Fab) immediately for this massive overdose 2, 3, 4. The administration of more than 10 mg of digoxin in a previously healthy adult often results in cardiac arrest 4. At 100 mg, this patient faces imminent life-threatening toxicity including:

• Ventricular tachycardia or ventricular fibrillation
• Progressive bradyarrhythmias or complete heart block
• Massive hyperkalemia (potassium shift from intracellular to extracellular space)
• Cardiac arrest

Digoxin-Fab Dosing for Massive Overdose

For known ingestion amount: Calculate vials needed = (amount ingested in mg × 0.8) / 0.5. For 100 mg ingestion: (100 × 0.8) / 0.5 = 160 vials would be the calculated dose 4, 5.

However, recent evidence supports titrated dosing: Start with 10-20 vials and titrate based on clinical response, particularly for acute poisoning 6. One study showed that titrated doses (median 4 vials) were safe and effective, using only 25-35% of predicted doses based on amount ingested 6.

For life-threatening manifestations present: Administer large initial doses (10-20 vials or more) immediately 3, 5.

Supportive Care Measures

Critical "Do Not" Actions

• DO NOT administer potassium supplements - massive digitalis toxicity causes life-threatening hyperkalemia from intracellular potassium shift 4. Potassium administration is contraindicated and potentially fatal in massive overdose.
• DO NOT use hemodialysis, hemofiltration, hemoperfusion, or plasmapheresis - these are ineffective for digoxin removal 3.

Gastrointestinal Decontamination

Administer activated charcoal immediately if the patient presents within 2 hours and is alert 4. Large doses should be given to prevent absorption and bind digoxin during enterohepatic recirculation.

Avoid gastric lavage or induced emesis if the patient is obtunded or presents >2 hours post-ingestion, as vagal stimulation can worsen digoxin-related arrhythmias 4.

Electrolyte Management

• Monitor potassium closely - expect hyperkalemia initially. If hyperkalemia is acutely life-threatening, treat with glucose and insulin while awaiting digoxin-Fab effect 4.
• Maintain normal magnesium levels - hypomagnesemia increases toxicity risk 1.
• Monitor calcium - hypercalcemia predisposes to toxicity, but calcium may be needed for hyperkalemia management (use cautiously) 4.

Cardiac Monitoring and Arrhythmia Management

Continuous cardiac monitoring is mandatory. Expected manifestations include 1, 2:

• Ventricular arrhythmias (ectopic rhythms, VT, VF)
• Bradyarrhythmias with AV block
• Enhanced automaticity with conduction block
• Bidirectional or fascicular VT (highly suggestive of digoxin toxicity)

For symptomatic bradycardia or heart block: Consider atropine (though variable effectiveness) or temporary pacing while awaiting digoxin-Fab effect 2, 3, 4. Note that pacing may require higher-than-normal current and has 36% complication rate 3.

For ventricular arrhythmias: Lidocaine, phenytoin, or bretylium may be used as temporizing measures until digoxin-Fab takes effect 2, 3.

Expected Clinical Course

Toxicity Manifestations

With a 100 mg dose, expect severe manifestations 1:

• Gastrointestinal: Anorexia, nausea, vomiting (88% in acute poisoning) 6
• Neurological: Visual disturbances (yellow-green halos), confusion, disorientation
• Cardiac: Life-threatening arrhythmias, cardiac arrest
• Metabolic: Severe hyperkalemia, acute kidney injury (20% of cases) 6

Response to Digoxin-Fab

Expect rapid response: Dysrhythmia resolution typically occurs within 30-45 minutes, with response rates of 50-90% 3. Free digoxin concentrations drop to nearly zero after any dose of digoxin-Fab 6.

Monitor for rebound toxicity: Free digoxin concentrations may rebound to >2.6 nmol/L (>2 µg/L) as antibody-bound digoxin redistributes 6. Continue monitoring for at least 24-48 hours post-treatment.

Common Pitfalls to Avoid

1. Assuming this is a therapeutic dose - 100 mg is never appropriate; standard doses are 0.125-0.25 mg daily
2. Giving potassium for "low" levels - hyperkalemia is expected and potassium is contraindicated
3. Delaying digoxin-Fab - this is the definitive treatment and should not be delayed
4. Attempting dialysis - completely ineffective for digoxin removal
5. Aggressive gastric decontamination in obtunded patients - risks vagal stimulation and worsening arrhythmias

Correct Therapeutic Dosing (For Reference)

Standard maintenance dose: 0.125-0.25 mg daily 1

Reduced doses required for:

• Age >70 years: 0.125 mg daily or every other day
• Impaired renal function
• Low lean body mass
• Drug interactions (amiodarone, dronedarone, verapamil, quinidine, clarithromycin, erythromycin, itraconazole, cyclosporine, propafenone) 1

Target serum concentration: 0.5-0.9 ng/mL 1. Concentrations >2 ng/mL are associated with overt toxicity, though toxicity can occur at lower levels with electrolyte abnormalities 1.

Higher doses (0.375-0.50 mg daily) are rarely needed or used 1. There is no reason to use loading doses in heart failure patients 1.